Fibronectin in malignancy: Cancer-specific alterations, protumoral effects, and therapeutic implications

Bissell, 2001, Putting tumours in context, Nat Rev Cancer, 1, 46, 10.1038/35094059 Qin, 2017, Laminins and cancer stem cells: partners in crime?, Semin Cancer Biol, 45, 3, 10.1016/j.semcancer.2016.07.004 Venning, 2015, Targeting ECM disrupts cancer progression, Front Oncol, 5, 224, 10.3389/fonc.2015.00224 Noy, 2014, Tumor-associated macrophages: from mechanisms to therapy, Immunity, 41, 49, 10.1016/j.immuni.2014.06.010 Kalluri, 2006, Fibroblasts in cancer, Nat Rev Cancer, 6, 392, 10.1038/nrc1877 Yang, 2017, Tumor-associated macrophages: from basic research to clinical application, J Hematol Oncol, 10, 58, 10.1186/s13045-017-0430-2 Wang, 2017, Pro-tumor activities of macrophages in the progression of melanoma, Hum Vaccin Immunother, 13, 1556, 10.1080/21645515.2017.1312043 Lu, 2012, The extracellular matrix: a dynamic niche in cancer progression, J Cell Biol, 196, 395, 10.1083/jcb.201102147 Givant-Horwitz, 2005, Laminin-induced signaling in tumor cells, Cancer Lett, 223, 1, 10.1016/j.canlet.2004.08.030 Ruoslahti, 1999, Fibronectin and its integrin receptors in cancer, Adv Cancer Res, 76, 1, 10.1016/S0065-230X(08)60772-1 Frantz, 2010, The extracellular matrix at a glance, J Cell Sci, 123, 4195, 10.1242/jcs.023820 Neve, 2014, Extracellular matrix modulates angiogenesis in physiological and pathological conditions, Biomed Res Int, 2014, 10.1155/2014/756078 Tian, 2013, High-molecular-mass hyaluronan mediates the cancer resistance of the naked mole rat, Nature, 499, 346, 10.1038/nature12234 Gopal, 2017, Fibronectin-guided migration of carcinoma collectives, Nat Commun, 8, 14105, 10.1038/ncomms14105 Frantz, 2010, The extracellular matrix at a glance, J Cell Sci, 123, 4195, 10.1242/jcs.023820 Kim, 2011, Extracellular matrix and cell signalling: the dynamic cooperation of integrin, proteoglycan and growth factor receptor, J Endocrinol, 209, 139, 10.1530/JOE-10-0377 White, 2011, Fibronectin splice variants: Understanding their multiple roles in health and disease using engineered mouse models, IUBMB Life, 63, 538, 10.1002/iub.493 To, 2011, Plasma and cellular fibronectin: distinct and independent functions during tissue repair, Fibrogenesis Tissue Repair, 4, 21, 10.1186/1755-1536-4-21 Maurer, 2015, Dynamic structure of plasma fibronectin, Crit Rev Biochem Mol Biol, 51, 213, 10.1080/10409238.2016.1184224 Zerlauth, 1984, Plasma fibronectin as a marker for cancer and other diseases, Am J Med, 77, 685, 10.1016/0002-9343(84)90366-8 To, 2011, Plasma and cellular fibronectin: distinct and independent functions during tissue repair, Fibrogenesis Tissue Repair, 4, 21, 10.1186/1755-1536-4-21 Kim, 2017, Serum fibronectin distinguishes the early stages of hepatocellular carcinoma, Sci Rep, 7, 9449, 10.1038/s41598-017-09691-3 Zand, 2003, Differential effects of cellular fibronectin and plasma fibronectin on ovarian cancer cell adhesion, migration and invasion, Vitr Cell Dev Biol, 39, 178, 10.1007/s11626-003-0013-0 Adachi, 1998, Fibronectin production by cultured human lung fibroblasts in three-dimensional collagen gel culture, Vitro Cell Dev Biol Anim, 34, 203, 10.1007/s11626-998-0125-7 Gopal, 2017, Fibronectin-guided migration of carcinoma collectives, Nat Commun, 8, 14105, 10.1038/ncomms14105 White, 2011, Fibronectin splice variants: Understanding their multiple roles in health and disease using engineered mouse models, IUBMB Life, 63, 538, 10.1002/iub.493 Singh, 2010, Assembly of fibronectin extracellular matrix, Annu Rev Cell Dev Biol, 26, 397, 10.1146/annurev-cellbio-100109-104020 Missirlis, 2017, Fibronectin promotes directional persistence in fibroblast migration through interactions with both its cell-binding and heparin-binding domains, Sci Rep, 7, 3711, 10.1038/s41598-017-03701-0 Koukoulis, 1993, Distribution of tenascin, cellular fibronectins and integrins in the normal, hyperplastic and neoplastic breast, J Submicrosc Cytol Pathol, 25, 285 Oyama, 1990, Oncodevelopmental regulation of the alternative splicing of fibronectin pre-messenger RNA in human lung tissues, Cancer Res, 50, 1075 Ruoslahti, 1984, Fibronectin in cell adhesion and invasion, Cancer Metastasis Rev, 3, 43, 10.1007/BF00047692 To, 2011, Plasma and cellular fibronectin: distinct and independent functions during tissue repair, Fibrogenesis Tissue Repair, 4, 21, 10.1186/1755-1536-4-21 Sadlonova, 2009, Identification of molecular distinctions between normal breast-associated fibroblasts and breast cancer-associated fibroblasts, Cancer Microenviron, 2, 9, 10.1007/s12307-008-0017-0 Kojima, 2010, Autocrine TGF- and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts, Proc Natl Acad Sci, 107, 20009, 10.1073/pnas.1013805107 Shiga, 2015, Cancer-associated fibroblasts: their characteristics and their roles in tumor growth, Cancers (Basel), 7, 2443, 10.3390/cancers7040902 Ishii, 2003, Bone-marrow-derived myofibroblasts contribute to the cancer-induced stromal reaction, Biochem Biophys Res Commun, 309, 232, 10.1016/S0006-291X(03)01544-4 Jotzu, 2010, Adipose tissue-derived stem cells differentiate into carcinoma-associated fibroblast-like cells under the influence of tumor-derived factors, Anal Cell Pathol (Amst), 33, 61, 10.1155/2010/695162 Direkze, 2004, Bone marrow contribution to tumor-associated myofibroblasts and fibroblasts, Cancer Res, 64, 8492, 10.1158/0008-5472.CAN-04-1708 Quante, 2011, Bone marrow-derived myofibroblasts contribute to the mesenchymal stem cell niche and promote tumor growth, Cancer Cell, 19, 257, 10.1016/j.ccr.2011.01.020 Potenta, 2008, The role of endothelial-to-mesenchymal transition in cancer progression, Br J Cancer, 99, 1375, 10.1038/sj.bjc.6604662 Zeisberg, 2007, Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts, Cancer Res, 67, 10123, 10.1158/0008-5472.CAN-07-3127 Huang, 2016, c-Met-mediated endothelial plasticity drives aberrant vascularization and chemoresistance in glioblastoma, J Clin Invest, 126, 1801, 10.1172/JCI84876 Nair, 2017, A cancer stem cell model as the point of origin of cancer-associated fibroblasts in tumor microenvironment, Sci Rep, 7, 6838, 10.1038/s41598-017-07144-5 Wang, 2016, Fibronectin mechanobiology regulates tumorigenesis, Cell Mol Bioeng, 9, 1, 10.1007/s12195-015-0417-4 Wang, 2017, Fibronectin: how its aberrant expression in tumors may improve therapeutic targeting, J Cancer, 8, 674, 10.7150/jca.16901 Pulina, 2011, Essential roles of fibronectin in the development of the left-right embryonic body plan, Dev Biol, 354, 208, 10.1016/j.ydbio.2011.03.026 de Almeida, 2016, Fibronectin assembly during early embryo development: a versatile communication system between cells and tissues, Dev Dyn, 245, 520, 10.1002/dvdy.24391 Lenselink, 2015, Role of fibronectin in normal wound healing, Int Wound J, 12, 313, 10.1111/iwj.12109 Erdogan, 2017, Cancer-associated fibroblasts promote directional cancer cell migration by aligning fibronectin, J Cell Biol, 216, 3799, 10.1083/jcb.201704053 Attieh, 2017, Cancer-associated fibroblasts lead tumor invasion through integrin-β3-dependent fibronectin assembly, J Cell Biol, 216, 3509, 10.1083/jcb.201702033 Zeng, 2006, Role of focal adhesion kinase and phosphatidylinositol 3′-kinase in integrin fibronectin receptor-mediated, matrix metalloproteinase-1-dependent invasion by metastatic prostate cancer cells, Cancer Res, 66, 8091, 10.1158/0008-5472.CAN-05-4400 Bouchard, 2007, Fak/Src signaling in human intestinal epithelial cell survival and anoikis: differentiation state-specific uncoupling with the PI3-K/Akt-1 and MEK/Erk pathways, J Cell Physiol, 212, 717, 10.1002/jcp.21096 Balanis, 2013, Epithelial to mesenchymal transition promotes breast cancer progression via a fibronectin-dependent STAT3 signaling pathway, J Biol Chem, 288, 17954, 10.1074/jbc.M113.475277 Meng, 2009, Characterisation of fibronectin-mediated FAK signalling pathways in lung cancer cell migration and invasion, Br J Cancer, 101, 327, 10.1038/sj.bjc.6605154 Yousif, 2014, Fibronectin promotes migration and invasion of ovarian cancer cells through up-regulation of FAK-PI3K/Akt pathway, Cell Biol Int, 38, 85, 10.1002/cbin.10184 Mitra, 2011, Ligand-independent activation of c-Met by fibronectin and α5β1-integrin regulates ovarian cancer invasion and metastasis, Oncogene, 30, 1566, 10.1038/onc.2010.532 Illario, 2005, Fibronectin-induced proliferation in thyroid cells is mediated by αvβ3 integrin through Ras/Raf-1/MEK/ERK and Calcium/CaMKII Signals, J Clin Endocrinol Metab, 90, 2865, 10.1210/jc.2004-1520 Kenny, 2014, Mesothelial cells promote early ovarian cancer metastasis through fibronectin secretion, J Clin Invest, 124, 4614, 10.1172/JCI74778 Han, 2006, Fibronectin induces cell proliferation and inhibits apoptosis in human bronchial epithelial cells: pro-oncogenic effects mediated by PI3-kinase and NF-κB, Oncogene, 25, 4341, 10.1038/sj.onc.1209460 Scott, 1997, Fibronectin suppresses apoptosis in normal human melanocytes through an integrin-dependent mechanism, J Invest Dermatol, 108, 147, 10.1111/1523-1747.ep12332650 George, 1993, Defects in mesoderm, neural tube and vascular development in mouse embryos lacking fibronectin, Development, 119, 1079, 10.1242/dev.119.4.1079 Francis, 2002, Central roles of alpha5beta1 integrin and fibronectin in vascular development in mouse embryos and embryoid bodies, Arterioscler Thromb Vasc Biol, 22, 927, 10.1161/01.ATV.0000016045.93313.F2 Schaffner, 2013, Integrin α5β1, the fibronectin receptor, as a pertinent therapeutic target in solid tumors, Cancers (Basel), 5, 27, 10.3390/cancers5010027 Astrof, 2009, Fibronectins in vascular morphogenesis, Angiogenesis, 12, 165, 10.1007/s10456-009-9136-6 Nicosia, 1993, Fibronectin promotes the elongation of microvessels during angiogenesis in vitro, J Cell Physiol, 154, 654, 10.1002/jcp.1041540325 Newman, 2011, The requirement for fibroblasts in angiogenesis: fibroblast-derived matrix proteins are essential for endothelial cell lumen formation, Mol Biol Cell, 22, 3791, 10.1091/mbc.e11-05-0393 Neve, 2014, Extracellular matrix modulates angiogenesis in physiological and pathological conditions, Biomed Res Int, 2014, 10.1155/2014/756078 Mongiat, 2016, Extracellular matrix, a hard player in angiogenesis, Int J Mol Sci, 17 Chen, 2012, Regulation of vascular endothelial growth factor expression by extra domain B segment of fibronectin in endothelial cells, Investig. Opthalmology Vis Sci, 53, 8333, 10.1167/iovs.12-9766 Wijelath, 2004, Fibronectin promotes VEGF-induced CD34+ cell differentiation into endothelial cells, J Vasc Surg, 39, 655, 10.1016/j.jvs.2003.10.042 Astrof, 2004, Direct test of potential roles of EIIIA and EIIIB alternatively spliced segments of fibronectin in physiological and tumor angiogenesis, Mol Cell Biol, 24, 8662, 10.1128/MCB.24.19.8662-8670.2004 Mateo, 2014, A first-in-human study of the anti-α5β1 integrin monoclonal antibody PF-04605412 administered intravenously to patients with advanced solid tumors, Cancer Chemother Pharmacol, 74, 1039, 10.1007/s00280-014-2576-8 Stupp, 2014, Lancet Oncol, 15, 1100, 10.1016/S1470-2045(14)70379-1 Murphy, 2015, Tumor angiogenesis in the absence of fibronectin or its cognate integrin receptors, PLoS One, 10, 10.1371/journal.pone.0120872 Kumra, 2016, Fibronectin-targeted drug delivery in cancer, Adv Drug Deliv Rev, 97, 101, 10.1016/j.addr.2015.11.014 M. Kaspar, L. Zardi, D. Neri, Fibronectin as target for tumor therapy, (n.d.). doi:10.1002/ijc.21677. Rekers, 2015, Long-lasting antitumor effects provided by radiotherapy combined with the immunocytokine L19-IL2, Oncoimmunology, 4, 10.1080/2162402X.2015.1021541 Eigentler, 2011, A dose-escalation and signal-generating study of the immunocytokine L19-IL2 in combination with dacarbazine for the therapy of patients with metastatic melanoma, Clin Cancer Res, 17, 7732, 10.1158/1078-0432.CCR-11-1203 Johannsen, 2010, The tumour-targeting human L19-IL2 immunocytokine: preclinical safety studies, phase I clinical trial in patients with solid tumours and expansion into patients with advanced renal cell carcinoma, Eur J Cancer, 46, 2926, 10.1016/j.ejca.2010.07.033 Schaffner, 2013, Integrin α5β1, the fibronectin receptor, as a pertinent therapeutic target in solid tumors, Cancers (Basel), 5, 27, 10.3390/cancers5010027 Bell-McGuinn, 2011, A phase II, single-arm study of the anti-α5β1 integrin antibody volociximab as monotherapy in patients with platinum-resistant advanced epithelial ovarian or primary peritoneal cancer, Gynecol Oncol, 121, 273, 10.1016/j.ygyno.2010.12.362 Ramakrishnan, 2006, Preclinical evaluation of an anti-alpha5beta1 integrin antibody as a novel anti-angiogenic agent, J Exp Ther Oncol, 5, 273 Bell-McGuinn, 2011, A phase II, single-arm study of the anti-α5β1 integrin antibody volociximab as monotherapy in patients with platinum-resistant advanced epithelial ovarian or primary peritoneal cancer, Gynecol Oncol, 121, 273, 10.1016/j.ygyno.2010.12.362